Search Tag: prostate cancer

NYRS 2022 - New York Roentgen Society Annual Meeting

2022 28 Sep

Find NYRS On Social Media Read more

Bracco Imaging launches new subsidiary, Blue Earth Therapeutics

2022 01 Mar

Innovative  rhPSMA Theranostic technology  has the potential to offer both diagnostic imaging and treatment for patients affected by prostate cancer.  Blue Earth Therapeutics  has exclusive worldwide rights to therapeutic applications of radiohybrid Prostate-Specific Membrane Antigen (rhPSMA) radiopharmaceutical technology. “ We are increasingly... Read more

Oncology Convention 2022

2022 15 Nov

Find European Oncology Congress on Social Media  Read more

AI-Powered Clinical Decision Support in Prostate Cancer Care

2021 09 Nov

Prostate cancer is a common disease that can often be quite tricky to deal with. It is a heterogeneous disease, with some patients having a very aggressive form of cancer while others with slower progression of the disease. Management and care of patients with prostate cancer is thus a complex and long-term challenge. Patients require surveillance,... Read more

Siemens Healthineers adds Lung Cancer to its AI Pathway Companion

2021 14 Oct

Siemens Healthineers recently added non-small cell lung cancer support to its AI Pathway Companion. Currently supported pathways are non-small cell lung and prostate cancer.   Siemens first presented its AI Pathway Companion at the 2018 Annual Meeting of the Radiological Society of North America in Chicago. In summary, the system delivers artificial... Read more

Clinical Decision Support for Prostate Cancer Care

2021 08 Oct

Executive Summary  Cancer care is becoming increasingly complex and personalized. More and more patient characteristics and disease specific data – clinical history, comorbidities, imaging, laboratory data, genomics/ proteomics, lifestyle factors, pathology results – have to be factored in when deciding on diagnostic measures and care pathways.... Read more

#ESCCongress: PRONOUNCE Trial - Safety of ADT Remains Unresolved

2021 30 Aug

Late-breaking research from the PRONOUNCE trial was presented in a Hot Line session at ESC Congress 2021. The cardiovascular safety of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the trial was terminated early.   Every year, approximately one million men are diagnosed with prostate cancer worldwide. These patients... Read more

Biparametric MRI: A New Standard for Prostate Cancer Imaging?

2021 12 Jul

A lone and discordant voice supported by few at first, biparametric prostate magnetic resonance imaging has been gradually gaining attention and visibility as a reliable, faster, and cheaper alternative to conventional multiparametric magnetic resonance imaging and could become a new standard of care in the near future. Key Points The role... Read more

Diagnosing Prostate Cancer Using Artificial Intelligence

2021 25 Jan

Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer based on Prostate-Specific Antigen (PSA), a prostate-specific antigen used as an index for the screening of prostate cancer. However, diagnostic accuracy for prostate cancer is as low as 30%. That is why a large number of patients have to undergo... Read more

Cancer Care: What to Expect, What to Do

2020 21 Apr

A research predicts a decline in cancer mortality rates in 2020 in the EU. However, due to the COVID-19 pandemic cancer patient safety is compromised, but can still be improved with certain policies.   You may also like : Prostate is Now Most Common Cancer   Cancer in the EU Total cancer mortality rates in the... Read more